Potential of bone marrow mesenchymal stem cells in rejuvenation of the aged skin of rats.

The aim of the present study was to evaluate the anti-aging effects of bone marrow-mesenchymal stem cells (BM-MSCs) in a D-galactose-induced skin aging rat model. Male Sprague Dawley rats were randomly divided into four groups (n=10/group) as follows: Normal control group; skin aging model group; MSC-treated group by subcutaneous multi-point injection. The skin aging model was established by a daily subcutaneous injection of 15% D-galactose (1,000 mg/kg) for 8 weeks. Rats in the MSC-treated groups were administered 3×106/ml BM-MSCs/green fluorescent protein (GFP) for 4 weeks, administered once per week. Oxidative/antioxidative parameters were evaluated, and morphological and ultrastructure analyses were performed. Rats in the model group exhibited the typical changes of aging skin. Compared with the control group, rats in the model group had significantly increased malondialdehyde (MDA) content (P<0.01), and decreased serum superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities (P<0.05). MSC treatment markedly ameliorated aging-induced oxidative stress in the skin. Histologically, rats in the model group exhibited loosely arranged epidermal cell layers and disorganized collagen fibers. BM-MSC treatment significantly improved the histological abnormalities, which was similar to those in the control group. In addition, 7 days after the final cell transplantation, GFP-positive cells were observed by fluorescence microscopy to be distributed in the dermis. Injection of BM-MSCs significantly improved the D-galactose-induced histological abnormalities of the skin, by promoting an antioxidant response and ameliorating oxidative stress in aged skin. Thus, BM-MSCs may be beneficial in the rejuvenation of aged skin.

Introduction

Skin maintains various homeostatic processes of the body and acts as the first defense barrier against infection, radiation and toxin exposure. However, skin is easily affected by the natural aging process (i.e., intrinsic aging), as well as environmental conditions (i.e., extrinsic aging), undergoing aging-associated phenotypic and functional alterations in the cellular and extracellular components (1,2). Skin aging is a biological, inevitable process accompanied by a decreased regenerative capacity, loss of dermal elasticity, impaired function of the skin, and increased risk of cancer (3). Histologically, aging of the skin results in altered epidermal architecture and morphology, reduced dermal mast cells and fibroblasts, decreased collagen production, epidermal thinning and diminished dermis vasculature (4,5). Mechanisms for aging skin include exacerbated formation of free radicals (reactive oxygen species; ROS), accumulation of mitochondrial DNA mutations, progressive telomere shortening, ultraviolet (UV) radiation, inflammation and hormonal changes, as well as other factors that, taken together or alone, may accelerate skin aging (6–8). However, currently there are a variety of anti-aging agents (7,8), which are routinely used, although their therapeutic efficiency is less than satisfactory. Therefore, novel therapeutic strategies for the rejuvenation of aged skin are urgently required.

Mesenchymal stem cells (MSCs) are rare multipotent stem cells of mesenchymal origin. Through identification with specific surface markers, MSCs are isolated from the majority of human tissue types, including bone marrow, adipose tissues, umbilical cord blood and the dermis (9). MSCs derived from bone marrow (BM-MSCs) possess remarkable self-renewing properties and exhibit a multipotent differentiation profile under appropriate differentiation conditions in vivo and in vitro (10,11). MSCs facilitate tissue repair via cell replacement from differentiated cells and/or remodeling the microenvironment by releasing chemokines and growth factors. MSCs, therefore, facilitate a variety of basic and clinical studies for the treatment of a plethora of congenital and acquired diseases (12). MSCs have been reported to accelerate the healing of cutaneous wounds by systemic and/or local administration (13–15). Animal experiments have confirmed the anti-apoptotic and anti-oxidative capacities of MSCs (16), therefore, these cells may be considered as an alternative therapeutic strategy for skin rejuvenation. Conditioned serum-free medium from umbilical cord-derived MSCs may protect against photo-aging induced by UV radiation in mouse skin (17). Furthermore, adipose-derived MSCs have been reported to improve UV radiation-induced wrinkles and protect photo-aged dermal fibroblasts from oxidative stress (18,19).

However, the underlying mechanisms by which BM-MSCs exert their anti-aging effects have not been extensively investigated. The aim of the current study was to evaluate the anti-aging effects of BM-MSCs (using a skin aging model induced by intradermal injection of D-galactose), as well as the underlying mechanisms.

Materials and methods

Experimental animals

Thirty male Sprague-Dawley (SD) rats (age, 4–6 weeks), weighing 200±20 g, were purchased from the Experimental Animal Center, the General Hospital of the Chinese People Liberation Army (PLA; Beijing, China). They were maintained separately in a constant environment (room temperature, 20–22°C; room humidity, 40–60%, with free access to food and water) under a 12-h light/dark cycle. All procedures were performed with the approval of the Committee on the Use of Live Animals in Teaching and Research of the 309th Hospital of PLA.

Preparation and culture of rat BM-MSCs

BM-MSCs with green fluorescent protein (GFP) from SD rats were purchased from Cyagen Biosciences (Santa Clara, CA, USA). The cells were centrifuged at 500 × g (20–22°C) for 5 min and suspended in α-Minimum Essential Medium (Thermo Fisher Scientific, Grand Island, NY, USA) supplemented with Gibco 10% fetal bovine serum (Thermo Fisher Scientific) and then incubated at 37°C with 5% CO2. The cells were passaged at a ratio of 1:2 with 0.25% trypsin (Thermo Fisher Scientific), reseeded into new flasks and cultured until reaching 80% confluence. The fourth generation of BM-MSCs/GFP was collected, suspended in phosphate-buffered saline (PBS) and used to inject the rats.

Establishment of the rat model of skin aging

SD rats were randomly divided into three groups (n=10/group) as follows: Normal control group; aging model group; MSC-treated group (subcutaneous injection). The rats in the control group received a daily subcutaneous injection of sterile saline (1 ml), and the other three groups were administered a daily subcutaneous injection of 15% D-galactose (1,000 mg/kg in 1 ml sterile saline) for 8 weeks (20).

In vivo transplantation of BM-MSCs

Following successful preparation of the rat model of skin aging, rats in the MSC-treated groups were given 3×106/ml BM-MSCs/GFP in 1 ml PBS by subcutaneous multi-point injection at the midline of the dorsum for 4 weeks, which was administered once per week. Rats in the control and model groups were given the same quantity of PBS according to the same routine at the same time points. All animals were allowed free access to water and food, and were observed daily to assess the general condition of the rats.

Fluorescence analysis for labeling and trafficking of BM-MSCs in skin

The mice were sacrificed by cervical dislocation after the experiments, and the skin tissue was immediately collected and prepared for cryosectioning. Frozen sections (thickness, 30 µm) were sliced from the skin tissues of the dorsum and the GFP-positive cells were observed under a fluorescence microscope (IX-51; Olympus Corporation, Tokyo, Japan).

Morphological and ultrastructure analysis

Skin tissue samples from rats in each group were obtained and fixed in 4% paraformaldehyde for 12 h, then embedded in paraffin, and sliced into 5-µm sections. The sections were mounted on glass slides, dewaxed, rehydrated with distilled water, stained with hematoxylin and eosin, and observed under a light microscope. Van Gieson stain was used for collagen fiber staining.

For ultrastructural examination by transmission electron microscopy (TEM; FEI Tecnai™, Hillsboro, OR, USA), the skin tissue samples from rats were fixed in 2.5% pentanediol-2% paraformaldehyde in 0.1 mol/l sodium phosphate for 12 h at 4°C. After three washes with PBS, the samples were then secondarily fixed in 1% osmium tetroxide (osmic acid) for 1.5 h. The samples were thoroughly dehydrated in solutions of ethanol at increasing concentrations of 50, 70, 80, 90 and 100% for 10 min each, followed by immersion in 50% acetone for 1 h and in 33% acetone for 3 h. The samples were transferred into fresh epoxy resin and polymerized at 60°C for 48 h. Finally, the fixed tissues were thin-sectioned to 60–80 nm using an ultramicrotome and subsequently subjected to TEM for ultrastructural study.

Measurements of oxidant/antioxidant parameters

Skin tissue samples were homogenized in normal saline, and sonicated twice to produce homogenates, followed by centrifugation at 1,000 × g (20–22°C) for 10 min and 4,000 × g (4°C) for 15 min. The supernatant was collected and total proteins were quantified using the bicinchonic acid (BCA) method. The malondialdehyde (MDA) content, and superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities were determined using a total-SOD (T-SOD) assay kit (cat. no. A001-1), a MDA assay kit (cat. no. A003-1) and a GSH-PX assay kit (cat. no. A0005) according to the manufacturer's instructions (Jiancheng Biotech Co., Ltd., Nanjing, China). Briefly, the SOD activity was measured using the xanthine oxidase method at a wavelength of 550 nm, the MDA content was determined using the thiobarbituric acid colorimetric method at a wavelength of 532 nm and the GSH-Px activity was detected using the chemical colorimetric method at a wavelength of 412 nm. These oxidant/antioxidant indicators (SOD, MDA and GSH-Px activity) were measured using a 752 UV spectrophotometer (Hitachi, Ltd., Tokyo, Japan).

Statistical analysis

Statistical analysis was performed using SPSS software (version 12.0; SPSS, Inc, Chicago, IL, USA) and the quantitative data are presented as the mean ± standard deviation. Comparisons between two groups were performed by unpaired Student's t-test and P<0.05 was considered to indicate a statistically significant difference.

Results

General condition of the animals

The rats in the model group showed lower mood, reduced appetite and water consumption, reduced activity, dull fur and decreased skin elasticity in comparison with the rats in the control group. However, the MSC-treated groups showed improvement of these symptoms.

Comparison of oxidant/antioxidant parameters among groups

Compared with the control group, rats in the model group had a significantly increased MDA content (P<0.01), and significantly decreased serum GSH-Px and SOD activities (Table I; P<0.05). Treatment with 3×106 BM-MSCs by subcutaneous injection led to a significant increase in serum GSH-Px and SOD activities (P<0.05) and decrease in MDA content when compared with the model group (P<0.01), indicating that these treatments markedly ameliorated aging-induced oxidative stress in skin.

Table I.

Comparison of oxidant/antioxidant parameters among groups (n=10/group).

	Group (means ± standard deviation)
Parameter	Control	Model	Mesenchymal stem cell-treated
Malondialdehyde content (nmol/ml)	5.7±0.6	13.2±0.9[a]	8.6±0.5[b]
Superoxide dismutase activity (nU/ml)	148.1±10.1	95.0±7.5[c]	132.8±8.3[d]
Glutathione-Peroxidase activity (U/ml)	236.1±18.3	169.0±11.5[c]	201.9±15.1[d]

P<0.01 vs. control

P<0.05 vs. model

P <0.05 vs. control

P <0.05 vs. model.

Trafficking of BM-MSCs in skin

Seven days after the final cell transplantation, the GFP-positive cells were distributed in the dermis, which was observed by fluorescence microscopy (Fig. 1).

Figure 1.

Distribution of green fluorescent protein-positive cells in the dermis. The sections of skin were examined under (A) light and (B) fluorescence microscopes 7 days after the final bone marrow mesenchymal stem cell transplantation (magnification, ×100).

Histological and electron micrographic findings

Histological sections of skin tissue samples were stained with hematoxylin and eosin or Van Gieson stain, and examined microscopically (Fig. 2). Skin sections from the control group showed normal epidermal morphology with regular arrangement of epidermal cell layers and normal integral structures of the dermis. Collagen fibers were neatly and densely arranged, and interwoven into a network. Rats in the model group exhibited loosely arranged epidermal cell layers and disorganized collagen fibers. Following BM-MSC treatment for 4 weeks, the histological abnormalities significantly improved, which was evidenced by almost normal epidermal morphology and densely arranged collagen fibers, which were similar to those observed in the control group.

Figure 2.

Histological findings of skin tissue samples examined using hematoxylin and eosin (H&E) staining, and under light microscopy. (A) In the control group, following Van Gieson staining, the skin sections demonstrated normal epidermal morphology with regular arrangement of epidermal cell layers and normal integral structures of the dermis. The collagen fibers were neatly and densely arranged. (B) In the model group, the skin sections showed loosely arranged epidermal cell layers and disorganized collagen fibers. (C) In the bone marrow mesenchymal stem cell-treated group, the histological abnormalities were significantly improved, as evidenced by neatly and densely arranged collagen fibers, which were similar to those observed in the control group. Magnification, ×100.

To assess the protective effects of BM-MSCs on aging-induced skin lesions, ultrastructural analysis by TEM was performed on the skin tissue samples (Fig. 3). Rats in the control group showed abundant, well-developed rough endoplasmic reticulum and fibroblasts, surrounded by normal collagen fibers of dense connective tissue, which were arranged parallel to each other in neat rows within the dermal layer. In the model group, the number of rough endoplasmic reticulum was significantly reduced. The bundles of collagen fibers lost their regular arrangement and presented as a loosely connected network. In addition, broken or dissolved fibers were observed. Notably, subsequent to 4-week BM-MSC treatment, the rats demonstrated marked improvements in the ultrastructural abnormalities. Rough endoplasmic reticulum with normal appearance were clearly visible and the close arrangement of dermal collagen fibers was similar to those in the control group.

Figure 3.

Ultrastructural analysis of skin tissue samples using transmission electron microscopy. (A) Samples from the control group demonstrate abundant, well-developed rough ER and fibroblasts, surrounded by neatly arranged collagen fibers within the dermal layer. (B) Samples from the model group demonstrated a significantly reduced number of rough ER. The bundles of collagen fibers (including those that were broken or dissolved) were no longer neat and regularly arranged, and presented a loosely knit network. (C) In the samples from the bone marrow MSC-treated group, the MSCs restored the normal ER morphology and improved the ultrastructural abnormalities. ER, endoplasmic reticulum; MSC, mesenchymal stem cell.

Discussion

The present study provides evidence for the anti-aging effects of BM-MSCs against D-galactose-induced skin aging, as evidenced by substantial improvement in histological and ultrastructural abnormalities, decreased expression of the oxidant-associated marker, MDA and increases in the antioxidant markers, SOD and GSH-Px. In addition, the BM-MSCs were retained 7 days after being injected into dermal tissues.

The dermal structure is primarily composed of fibroblasts and extracellular matrix, which is rich in collagen and elastic fibers. The collagen-rich extracellular matrix is synthesized, organized and maintained by dermal fibroblasts. With age, fibroblast cells gradually decrease in number, and exhibit diminished capacity to synthesize collagen and elastic proteins, resulting in laxity and decreased skin elasticity. Histological and ultrastructural studies have revealed major alterations in the dermal extracellular matrix in aged skin, with reduced fibroblasts and decreased collagen production (5). Chronic injection with D-galactose at a wide range of dosages has been used to establish a skin aging model in rodents that resembles intrinsic aging, characterized by typical changes of aging skin in behavior, phenotype, histological appearance, as well as expression of senescence markers (e.g., SOD and MDA) (20–22). In the current study, rats in the model group were administered a daily subcutaneous injection of D-galactose (1,000 mg/kg) for 8 weeks. These rats showed poor mood, reduced appetite and water consumption, reduced activity, dull fur and decreased skin elasticity. In addition to typical symptoms of skin aging, this model appeared to exhibit an increase in MDA content and decrease in SOD and GSH-Px activity, and pathological characteristics of aged skin (including loosely arranged epidermal cell layers and disorganized collagen fibers) suggesting the successful establishment of a skin aging model in SD rats in this study.

The beneficial effect of MSCs on disease has been investigated in a variety of animal models and clinical trials. In particular, BM-MSCs contribute to cutaneous wound healing by promoting epidermal regeneration, as well as accelerating endothelial cell formation (23,24). BM-MSCs were originally described as plastic-adherent fibroblast-like cells that are capable of differentiating into a variety of cell types, including epidermal cells, endothelial cells and fibroblasts in the presence of appropriate factors in vitro and in vivo (15). Furthermore, MSCs enhance the functions of keratinocytes and dermal fibroblasts in a paracrine fashion (25). Thus, the potential of BM-MSCs in the rejuvenation of aged skin were evaluated. In the present study, BM-MSC treatment for 4 weeks restored D-galactose-induced histological abnormalities to levels similar to those of the controls. The present study hypothesized that through releasing cytokines and growth factors, such as vascular endothelial growth factor, platelet-derived growth factor, transforming growth factor-β, BM-MSCs promote the proliferation of fibroblasts, which stimulate production of collagen and elastic fibers (25). As a consequence, transplantation of BM-MSCs results in the activation of fibroblasts, enhancement of extracellular matrix, and thereby increases skin elasticity and reduces the appearance of wrinkles. Indeed, experimental studies of cutaneous wounds treated with MSCs revealed a relatively low level of direct engraftment of transplanted cells into the epidermis, with fewer cells retained over time (15). The low engraftment rate of transplanted cells and short-term retention rates are currently considered as barriers that potentially diminish the benefits of cell therapy (26). Thus, repeated transplants are proposed to enable the maximum therapeutic effect of MSCs. In the current study, rats in the MSC-treated groups were administered 3×106/ml BM-MSCs for 4 weeks, once per week. Seven days after the final cell transplantation, GFP-positive cells were observed to be distributed in the dermis under a fluorescence microscope. Consistently, MSCs have been reported to be detectable at 28 days after being injected into dermal tissues despite a low retention of transplanted cells (21). These data further indirectly confirm the anti-aging effects of MSCs in skin.

Oxidative stress is currently considered as a fundamental causative factor of aging, leading to intracellular lipid peroxidation, abnormal protein oxidation reactions and the accumulation of oxidative cellular damage (6). Aging appears to be a consequence of the imbalance between overwhelming ROS production beyond the scavenging ability, and substantial reduction in antioxidant defense during the aging process (27). Thus, attempts have been made to reduce excessive ROS in aged skin with the aim of improving, or even rejuvenating, aged skin (28). ROS degrade polyunsaturated lipids to form MDA, causing peroxidative tissue damage. SOD, an important antioxidant enzyme, functions to catalyze the dismutation of superoxide radicals to hydrogen peroxide and oxygen, defending the skin against ROS-induced oxidative deterioration of DNA, proteins and lipids by scavenging remaining ROS in cells (27). GSH-Px is a glutathione peroxidase that functions as an anti-oxidant by catalyzing the reduction of hydrogen peroxide to water and preventing lipid peroxidation (29). Zhang et al (21) demonstrated that D-galactose induced oxidative stress in mouse skin, as shown by the expression levels of increased MDA and decreased SOD. Consistent with these findings, the current study demonstrated that skin D-galactose-induced aging produced large quantities of lipid peroxide MDA accompanied by a decrease in the antioxidant enzymes, SOD and GSH-Px. Notably, MSCs have been reported to exhibit antioxidative activity under various conditions, by increasing the SOD and glutathione levels, and modulating the activation of antioxidant-associated proteins (30). Furthermore, MSCs exhibit potent antioxidant effects that provide protection for dermal fibroblasts and keratinocytes against oxidative stress, and consequently accelerate skin wound healing (31–33). In the present study, BM-MSCs were shown to cause a greater increase in serum GSH-Px and SOD activities, and a significant decrease in MDA content when compared with the model group. This indicates that BM-MSCs promote an antioxidant response and ameliorate aging-induced oxidative stress in the skin.

In conclusion, injection of BM-MSCs significantly improve D-galactose-induced histological and ultrastructural abnormalities of the skin, by promoting an antioxidant response and by ameliorating aging-induced oxidative stress in aged skin. Thus, BM-MSCs may be beneficial in the rejuvenation of aged skin. However, further investigation is required to determine the exact molecular mechanisms underlying the antioxidant effects of MSCs.